Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.

Biotechnology

Education

Seismic Therapeutic

Jo Viney

Melanie Manning

Yi Xing

Ivan Mascanfroni

Daniela Cipolletta

Jyothsna Visweswaraiah

John Sundy

Kevin Otipoby

Edward Freedman

Maude Tessier

Debora Marks

Nathan Higginson-Scott

The Academic Founders team at Seismic Therapeutic consists of leading experts in the fields of structural biology, protein engineering, and immunology. Leveraging their extensive research backgrounds and academic expertise, they provide foundational insights and innovative approaches to the biologics discovery process, facilitating the integration of machine learning with scientific exploration. This team's contributions are crucial in advancing Seismic Therapeutic’s mission to accelerate immunology drug development and address autoimmune diseases.

Academic Founders

Scientific Research and Development Team

Leadership Team

Directors and Managers

Academic Founders

About

Team members

Other teams at Seismic Therapeutic

Scientific Research and Development Team

Leadership Team

Directors and Managers